Exercise Therapy in Radiation Therapy
EXERT
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of this study is to evaluate exercise therapy as a method for potentially improving radiation therapy treatment toxicities for metastatic cancer patients receiving radiation therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2019
CompletedFirst Posted
Study publicly available on registry
April 5, 2019
CompletedStudy Start
First participant enrolled
February 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedMay 6, 2023
May 1, 2023
2 years
March 28, 2019
May 3, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Acceptability of exercise intervention: (number of patients agreeing to perform RT+ET)/(number approached)
(number of patients agreeing to perform RT+ET)/(number approached)
1 year
Feasibility of exercise intervention: (number of patients who completed RT+ET)/(number agreeing to perform RT+ET)
(number of patients who completed RT+ET)/(number agreeing to perform RT+ET)
1 year
Incidence of Treatment- Emergent Adverse Events
Safety of exercise intervention: freedom from any Common Terminology Criteria for Adverse Events (CTCAE) grade 3 or higher event
1 year
Secondary Outcomes (9)
Change in timed up and go
3 Months
change in grip strength
3 Months
change in quality of life measured via the Godin Physical Activity Questionnaire
3 Months
change in quality of life measured via the Barriers to Exercise RM 5-FM survey
3 Months
change in quality of life measured via the Work Productivity and Activity Impairment Questionnaire
3 Months
- +4 more secondary outcomes
Study Arms (1)
Exercise
EXPERIMENTALThe exercise intervention will utilize the "Moving Through Cancer: A Guide to Exercise for Cancer Survivors" framework. A certified cancer exercise physiologist will work through this guide at radiation therapy visits, with at least 1 visit per week, per the study schema. The cancer exercise physiologist will teach participants proper: warm ups, use of equipment, exercise form, modes of activity, intensity of exercise, flexibility exercises, and cool down. The cancer exercise physiologist will tailor the instruction to convey special considerations for exercise based on treatment and cancer type. The patient will perform supervised exercise in the Exercise Medicine Unit under the guidance of the cancer exercise specialist. The exercise done will be educational in nature (i.e. learning about proper walking form, proper intensity for a warmup/cool down, proper techniques for resistance exercises).
Interventions
Certified exercise oncology specialists will personalize, prescribe, and guide ET, including twice weekly resistance training and walking, performed at home, with supervision in the Exercise Medicine Unit. The cancer exercise physiologist will teach participants proper warm ups, use of equipment, exercise form, modes of activity, intensity of exercise, flexibility exercises, and cool down. In addition, patients will be instructed to exercise on their own, at home, according to the instructions from the cancer exercise specialist.
Eligibility Criteria
You may qualify if:
- Males and females ≥18 years of age
- Fluent in written and spoken English
- Must be able to provide and understand informed consent
- Must have an ECOG PS of ≤ 2
- Diagnosed with metastatic disease
- Cancer patients (stage 1-4)
- Treatment to primary site or metastatic disease
- Scheduled to receive radiation therapy at Penn State Cancer Institute
- Absence of absolute contraindications for exercise according to the American Heart Association (see below)
- Primary attending oncologist approval
- Receiving treatment as an outpatient
You may not qualify if:
- Receiving radiation therapy at a location other than Penn State Cancer Institute
- Not fluent in written and spoken English
- Evidence in the medical record of an absolute contraindication for exercise
- Performing \> 90 minutes/week of physical activity at the time of initial evaluation
- Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system
- History of acute coronary syndromes (including myocardial infarction and unstable angina), coronary angioplasty or stenting within the past 6 months prior to the start of radiation therapy
- Uncontrolled arrhythmias; patients with rate controlled atrial fibrillation for \>1 month prior to start of radiation therapy may be eligible
- syncope
- acute myocarditis, pericarditis, or endocarditis
- acute pulmonary embolus or pulmonary infarction
- thrombosis of lower extremities
- suspected dissecting aneurysm
- pulmonary edema
- respiratory failure
- acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen Sturgeon, PhD
Penn State College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 28, 2019
First Posted
April 5, 2019
Study Start
February 12, 2020
Primary Completion
January 26, 2022
Study Completion
January 31, 2023
Last Updated
May 6, 2023
Record last verified: 2023-05